The Disruptors: Bringing down barriers in novel medical technology (Video)

June 5, 2012 By MassDevice Leave a Comment

How do you change the world?

That’s the central question behind The Disruptors, a new web video series co-produced by MassDevice and HB, which focuses on the minds behind some of medical technology’s most disruptive innovations.

For the next several months we’ll be interviewing a select group of visionaries who we believe have changed or are going to change the world through disruptive medical technologies and processes.

In our inaugural episode, we introduce a true Disruptor: Abraham Gutman, CEO, AG Mednet.

Following a career in telecommunications, in which he founded Waltham, Mass.-based network access provider Emperative, Gutman took a flyer on changing the way drug and device companies share medical images during clinical trials.

MassDevice: How did AG Mednet come about?

Abraham Gutman: It was like most things in life, very serendipitous, I heard there’s a problem in radiology around moving images. There is another problem that there weren’t enough radiologists in the US. Why does the problem exists? Those machine must produce images in digital form and you just send them electronically, I’m a telecom guy, right?

The answer I was given was that there are many problems and complexities; compressions, different pax systems, HIPAA etc. And you know a few days later, in the middle of the night, I came to the conclusion that I can solve this problem.

MassDevice: How is technology received in healthcare?

AG: In healthcare, I think it’s the opposite. Nobody is willing to give technology a try. So there is plenty out there, but everyone seems to have reasons why we will not do; this but in telecom, the question is why we shouldn’t do this. In healthcare, no one can give me the reason why we should. They hide behind regulations and, in my opinion, they are guidance, not a mandate to not innovate.

MassDevice: What do you think is the future of healthcare technology?

AG: What I see as the barrier or unwillingness to accept innovations is going to begin to tumble because a big wave is coming. Just like in our case, we are in so many hospitals in the world. Our product does not require any IT intervention at a hospital. If I need to negotiate with 4,000 hospitals individually, we’ll never succeed because the barrier will be too high.

We built something that enables the user, just like they use google, yahoo or an EDC system, to built these submissions and enhanced quality images and move them. Well, we obviously are not the only ones who are doing this, but I know more and more innovation is occurring for iPad-based platforms and the canopy of platforms out there is increasing and development is becoming easier and everybody is attacking small problems not big ones.

That is one way which barriers are going to come down. Slowly but surely. It’s death by a thousand cuts.

Are you a Disruptor? Let us know how and maybe you’ll end up on one of these videos. Contact us at publisher@massdevice.com

Mojo Vision developing ‘smart’ contact lens
Mojo Vision is working with the FDA to develop a smart contact lens to help people with low vision. The lens overlays real-time contrast and lighting enhancements with zoom functionality and recently won FDA breakthrough device designation. “Receiving the Breakthrough Device Designation is a significant step in our research and development process. We look forward to… […]
FDA to EPA: Leave us out of your ethylene oxide rule
This article has been updated with comments from the FDA. The FDA has asked the Environmental Protection Agency to leave the FDA out of its proposal for stricter regulation of ethylene oxide (EtO) emissions, and the EPA complied. In an interagency comment on the EPA’s proposed rule governing commercial EtO users — which includes medical… […]
Clippart debuts stepper-controlled flow valve
Clippard recently launched a new stepper-controlled proportional valve for precision flow control. The Eclipse valve uses the industry’s most robust and powerful miniature linear actuator, according to Cincinnati-based Clippard. The patent-pending Eclipse is designed for liquid and gas delivery, medical, analytical and industrial automation requiring ultra-fine resolution and repeatability. The design also allows for custom… […]
Supporting regulatory affairs departments to address clinical requirements under new MDR
By Dietmar Falke and Jaap Laufer, Emergo Group The May 25, 2020 MDR deadline is approaching rapidly, and by now many medical device manufacturers are aware that the MDR requires the proactive collection of post-marketing clinical follow-up (PMCF) data. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog… […]
5 tips to raise funding for your medical device
Securing funding can be a long and tedious process, and medical device businesses must work to position themselves as especially attractive to potential investors to maximize success and accelerate the fundraising process. Jon Speer, Greenlight Guru According to Alejandro Cremades, author of The Art of Startup Fundraising, it can take from six to nine months… […]
FDA recognizes latest ISO 14971 as medical device consensus standard
By Mark Leimbeck and Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted Recognized Consensus Standard status to the third edition of the ISO 14071 risk management standard for medical devices and IVD products. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are… […]
Synaptive Medical updates Modus V surgical microscope
Synaptive Medical announced that its U.S. and Canadian Modus V robotic digital microscope now includes updates such as additional 3D visualization and voice-activated control. The Modus V is a robotically controlled digital microscope used as part of Synaptive’s BrightMatter surgical suite designed for less invasive, patient-specific approaches in complex cranial procedures. The Modus V provides similar… […]
New machine can preserve donor livers for 1 week
Researchers in Switzerland have built a perfusion machine that can preserve human livers for transplantation for a week or more, potentially slashing the number of donor livers that must be discarded due to time-related deterioration. Existing perfusion technology can preserve a donor liver for up to 24 hours. The team of surgeons, biologists and engineers… […]
Smiths Medical launches Portex tracheostomy tubes and kits
Smiths Medical this week launched its Portex polyvinyl chloride tracheostomy tube and kit portfolio. The new polyvinyl chloride (PVC) tube portfolio has options for a variety of patients, according to the company. “Our goal was to create tracheostomy tubes and kits designed to help clinicians provide the best patient care. We’re excited to offer a variety… […]
FDA clears Cleveland Clinic 3D-printed airway stents
The FDA recently cleared 3D-printed, patient-specific stents developed by a doctor at the Cleveland Clinic. Cleveland Clinic physician Tom Gildea developed the stents to keep open the airways of patients with serious breathing disorders caused by inflammation, trauma, tumors and other masses. Airway stents come in a limited number of sizes and shapes and are… […]
Boston Scientific shares drop on Q4 sales news
Shares in Boston Scientific (NYSE:BSX) dropped 8% this morning on news of disappointing fourth-quarter sales. The company’s preliminary earnings report showed sales for the quarter ended Dec. 31, 2019 coming in at $2.9 billion, below the $2.91 billion that analysts were expecting. The unaudited sales figure represents organic growth of 7.3%, missing the company’s own guidance of… […]